Clinical Showcase with Texas Medical Center (TMC)

The Texas Medical Center (TMC) is a globally recognised hub for healthcare innovation and a key potential partner for Danish health tech companies looking to grow in the US market. But when is the right time to engage, and what does a successful collaboration with TMC actually entail?

This online roundtable is designed to help Danish companies understand how TMC evaluates partnerships, its priorities in digital health innovation and how to approach it with relevance and readiness. With a mix of strategic insights and real-world examples, the session will clarify timing, expectations and how to align your solution with the needs of the TMC.

What to expect:

• A comprehensive overview of TMC’s innovation strategy and its engagement with international start-ups.
• Guidance on how to prepare for outreach and identify the right entry point.
• A curated showcase of up to ten Danish health tech companies
• An interactive Q&A session

Whether you are in the early stages of exploring the U.S. market or already in talks with clinical partners, this session will help you navigate TMC more strategically and ensure that every interaction counts.

About the Experts:

Devin Dunn, MPH

Director of Innovation Accelerators

Devin is the Director of Innovation Accelerators. In her role she collaborates with health tech companies to refine business models, hone value propositions and identify strategic needs.

Prior to joining TMCi, Devin was one of the first 10 employees at Series C funded Huma, a London based Digital Health company focused on Remote Patient Monitoring, Decentralized Clinical Trials and SaMD applications. Having worn many hats over a high growth period, most recently she led the Operations team in US market entry.

Devin is an experienced strategy consultant, having worked with provider systems, ACOs and integrated networks across the US in preparing for the transition to value-based care.

Devin earned her bachelor’s degree in Biological Basis of Behavior and Healthcare Management from the University of Pennsylvania. After moving to Houston, she received her Master’s in Public Health from the University of Texas Health Science Center.

Megan Noland, MHA, LSSBB

Program Manager for the TMCi HealthTech Accelerator

Megan is the Program Manager for the TMCi HealthTech Accelerator. The HealthTech Accelerator supports emerging digital health and medical device startups by connecting them to mentors, service providers, clinical champions, and corporate partners who share the commitment to improving access, quality, and cost of healthcare. Megan is passionate about supporting companies through their Accelerator journey and serving as a resource however they may need.

With a strong business and healthcare administration foundation, Megan brings a dynamic and analytical approach to the evolving healthcare landscape. A proud Texas A&M University graduate, Megan holds a Bachelor’s degree in Business Management from Mays Business School and a Master of Healthcare Administration from the School of Public Health. As a certified Lean Six Sigma Black Belt (LSSBB), Megan is confident in applying process improvement methodologies to drive efficiency and innovation in problem resolution.

Before joining TMC Innovation, Megan served as a Population Health Analyst at Harris Health, helping to develop data-driven strategies to enhance patient outcomes.

Emily Reiser, PhD

Director of Strategy and New Ventures

Dr. Emily Reiser is the Director of Strategy and New Ventures, spearheading the Accelerators for Cancer Therapeutics, Healthtech, and international BioBridge programs. Since joining TMC in 2019, she transitioned from direct engagement with startup founders to overseeing a vast stakeholder network and now leading the recruitment of entrepreneurs in residence. Prior to joining TMC, Emily lead Eventure, an entrepreneurial community organization empowering the next generation of talent in Houston. She also contributed to the successful launch of local medtech startup, Noleus Technologies.

Emily earned her bachelor’s degree in Biology from Emory University and a PhD in Bioengineering from Rice University, where her research focused on drug delivery for cancer immunotherapy.

Criteria for joining this event:

- You are a paying member of Health Tech Hub Copenhagen (HTHC).

If you are not yet a member and would like to find out more about the opportunities available at HTHC, please contact Line (line@healthtechhub.org) or Oded (oded@healthtechhub.org)